Frontiers in Pharmacology (Mar 2024)
Corrigendum: In vitro and in vivo antitumor activity of cucurbitacin C, a novel natural product from cucumber
- Dinglan Wu,
- Zhu Wang,
- Muqi Lin,
- Yi Shang,
- Fei Wang,
- JiaYi Zhou,
- Fei Wang,
- Xiantong Zhang,
- Xiaomin Luo,
- Weiren Huang
Affiliations
- Dinglan Wu
- Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Centre, Shenzhen Hospital, Southern Medical University, Shenzhen, China
- Zhu Wang
- Department of Urology, People’s Hospital of Longhua Shenzhen, Southern Medical University, Shenzhen, China
- Muqi Lin
- School of Pharmaceutical Sciences, Health Science Center, Shenzhen University, Shenzhen, China
- Yi Shang
- Agricultural Genome Institute at Shenzhen, Chinese Academy of Agricultural Science, Shenzhen, China
- Fei Wang
- Department of Urology, The Hospital of Hainan Province, Haikou, China
- JiaYi Zhou
- Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Centre, Shenzhen Hospital, Southern Medical University, Shenzhen, China
- Fei Wang
- Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Centre, Shenzhen Hospital, Southern Medical University, Shenzhen, China
- Xiantong Zhang
- Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Centre, Shenzhen Hospital, Southern Medical University, Shenzhen, China
- Xiaomin Luo
- Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Centre, Shenzhen Hospital, Southern Medical University, Shenzhen, China
- Weiren Huang
- Department of Urology, Shenzhen Second People’s Hospital, The First Affiliated Hospital of Shenzhen University, International Cancer Center, Shenzhen University School of Medicine, Shenzhen, China
- DOI
- https://doi.org/10.3389/fphar.2024.1334971
- Journal volume & issue
-
Vol. 15
Abstract
No abstracts available.Keywords